X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (53) 53
humans (49) 49
female (40) 40
male (40) 40
mortality (38) 38
risk factors (36) 36
medical and health sciences (35) 35
medicin och hälsovetenskap (35) 35
middle aged (34) 34
aged (33) 33
diabetes (31) 31
diabetes mellitus (30) 30
endocrinology & metabolism (29) 29
clinical medicine (27) 27
prognosis (27) 27
klinisk medicin (26) 26
myocardial infarction (24) 24
cardiac & cardiovascular systems (23) 23
cardiovascular disease (22) 22
glucose (20) 20
heart failure (18) 18
heart attacks (16) 16
insulin (16) 16
peripheral vascular disease (16) 16
type 2 diabetes (16) 16
diabetes mellitus, type 2 - complications (14) 14
heart attack (14) 14
cardiovascular diseases (13) 13
diabetes mellitus, type 2 - drug therapy (13) 13
hypoglycemic agents - therapeutic use (13) 13
endocrinology and diabetes (12) 12
endokrinologi och diabetes (12) 12
myocardial infarction - mortality (12) 12
prevalence (12) 12
sweden - epidemiology (12) 12
abridged index medicus (11) 11
blood glucose - metabolism (11) 11
cardiac and cardiovascular systems (11) 11
diabetes-mellitus (11) 11
diagnosis (11) 11
follow-up studies (11) 11
heart diseases (11) 11
kardiologi (11) 11
patients (11) 11
risk (11) 11
treatment outcome (11) 11
mellitus (10) 10
outcomes (10) 10
diabetes mellitus, type 2 - mortality (9) 9
medicine (9) 9
myocardial infarction - complications (9) 9
sweden (9) 9
therapy (9) 9
time factors (9) 9
coronary-artery-disease (8) 8
dextrose (8) 8
diabetes mellitus, type 2 - blood (8) 8
health aspects (8) 8
insulin - therapeutic use (8) 8
myocardial infarction - epidemiology (8) 8
myocardial-infarction (8) 8
sodium (8) 8
acute myocardial-infarction (7) 7
adult (7) 7
artery-disease (7) 7
glucose tolerance test (7) 7
health risk assessment (7) 7
heart-failure (7) 7
periodontitis (7) 7
proportional hazards models (7) 7
registries (7) 7
acute coronary syndrome (6) 6
association (6) 6
biomarkers (6) 6
biomarkers - blood (6) 6
cardiovascular diseases - etiology (6) 6
coronary-heart-disease (6) 6
dapagliflozin (6) 6
diabetes mellitus, type 2 - diagnosis (6) 6
diabetes mellitus, type 2 - epidemiology (6) 6
drugs (6) 6
epidemiology (6) 6
heart (6) 6
medical research (6) 6
medicin (6) 6
myocardial infarction - blood (6) 6
myocardial infarction - therapy (6) 6
original (6) 6
population (6) 6
prospective studies (6) 6
survival analysis (6) 6
acute myocardial infarction (5) 5
aged, 80 and over (5) 5
all-cause mortality (5) 5
cardiovascular diseases - epidemiology (5) 5
cardiovascular diseases - prevention & control (5) 5
case-control studies (5) 5
cause of death (5) 5
cerebral infarction (5) 5
clinical trials (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet Diabetes & Endocrinology, ISSN 2213-8587, 07/2018, Volume 6, Issue 7, pp. 517 - 519
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2016, Volume 68, Issue 13, pp. 1404 - 1416
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2015, Volume 10, Issue 7, pp. e0126370 - e0126370
Background and Objective Matrix metalloproteinase (MMP) -8, -9 and myeloperoxidase (MPO) are inflammatory mediators. The potential associations between MMP-8,... 
NEUTROPHIL COLLAGENASE | ACTIVATION | INHIBITION | UNIVERSAL DEFINITION | BIOMARKER | MULTIDISCIPLINARY SCIENCES | INVOLVEMENT | MATRIX-METALLOPROTEINASE-9 | GINGIVAL CREVICULAR FLUID | TIMPS | PREVALENCE | Myocardial Infarction - epidemiology | Comorbidity | Coronary Artery Disease - metabolism | Humans | Middle Aged | Risk Factors | Male | Coronary Artery Disease - drug therapy | Myocardial Infarction - metabolism | Saliva - enzymology | Case-Control Studies | Myocardial Infarction - complications | Tissue Inhibitor of Metalloproteinase-1 - metabolism | Matrix Metalloproteinase 9 - metabolism | Matrix Metalloproteinase 8 - metabolism | Coronary Artery Disease - complications | Biomarkers | Female | Aged | Coronary Artery Disease - epidemiology | Chronic Periodontitis - metabolism | Chronic Periodontitis - epidemiology | Chronic Periodontitis - complications | Peroxidase - metabolism | Enzymes | Medical research | Periodontitis | Cardiac patients | Medicine, Experimental | Enzyme-linked immunosorbent assay | Heart attack | Myocardial infarction | Heart | Heart attacks | Cardiovascular disease | Matrix metalloproteinase | Tissue inhibitor of metalloproteinase 1 | Gingivitis | Dental materials | Peroxidase | Bioindicators | Metalloproteinase | Cardiology | Heart diseases | Coronary artery | Health risks | Inflammation | Dentistry | Coronary artery disease | Patients | Periodontal diseases | Medicine | Residential areas | Hospitals | Neutrophil collagenase | Infarction | Immunofluorescence | Cardiovascular diseases | Saliva | Smoking | Index Medicus | ODONTOLOGY | ODONTOLOGI | Multidisciplinary Sciences | Technology
Journal Article
Diabetologia, ISSN 0012-186X, 8/2016, Volume 59, Issue 8, pp. 1692 - 1701
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 02/2018, Volume 20, Issue 2, pp. 344 - 351
Aims To compare the sodium-glucose-cotransporter-2 (SGLT-2) inhibitor dapagliflozin with dipeptidyl peptidase-4 (DPP-4) inhibitors with regard to risk... 
cardiovascular disease | type 2 diabetes | DPP | hypoglycaemia | dapagliflozin | diabetes complications | 4 inhibitor | DPP-4 inhibitor | REGISTER | SEVERE HYPOGLYCEMIA | MONOTHERAPY | HEART-FAILURE | PREVALENCE | COMBINATION | METFORMIN TREATMENT | INSULIN | DRUGS | ENDOCRINOLOGY & METABOLISM | DPP-4 INHIBITORS | Diabetic Cardiomyopathies - ethnology | Cardiovascular Diseases - ethnology | Follow-Up Studies | Dipeptidyl-Peptidase IV Inhibitors - adverse effects | Cardiovascular Diseases - prevention & control | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Humans | Middle Aged | Male | Risk | Diabetes Mellitus, Type 2 - metabolism | Incidence | Hypoglycemia - prevention & control | Cardiovascular Diseases - complications | Diabetes Mellitus, Type 2 - ethnology | Benzhydryl Compounds - adverse effects | Cardiovascular Diseases - epidemiology | Diabetic Cardiomyopathies - prevention & control | Female | Glucosides - therapeutic use | Diabetic Angiopathies - prevention & control | Hypoglycemia - chemically induced | Benzhydryl Compounds - therapeutic use | Diabetes Mellitus, Type 2 - complications | Glucosides - adverse effects | Hyperglycemia - prevention & control | Sodium-Glucose Transporter 2 - metabolism | Kaplan-Meier Estimate | Proportional Hazards Models | Diabetic Angiopathies - ethnology | Sweden - epidemiology | Diabetic Cardiomyopathies - epidemiology | Norway - epidemiology | Denmark - epidemiology | Membrane Transport Modulators - therapeutic use | Diabetic Angiopathies - epidemiology | Aged | Diabetes Mellitus, Type 2 - drug therapy | Membrane Transport Modulators - adverse effects | Type 2 diabetes | Heart | Complications and side effects | Comorbidity | Atrial fibrillation | Glucose | Comparative analysis | Risk factors | Heart attack | Dextrose | Diabetes therapy | Myocardial infarction | Cerebral infarction | Cardiac arrhythmia | Heart attacks | Peptidase | Mortality | Diabetes mellitus | Hypoglycemia | Patients | Fibrillation | Sodium | Diabetes | Cardiovascular diseases | Health risk assessment | Diabetes mellitus (non-insulin dependent) | Heart diseases | Index Medicus | DPP‐4 inhibitor | Original | Clinical Medicine | Medical and Health Sciences | Endokrinologi och diabetes | Medicin och hälsovetenskap | Klinisk medicin | Endocrinology and Diabetes
Journal Article
Diabetes, ISSN 0012-1797, 06/2019, Volume 68, Issue Supplement 1, p. 232
The aim was to describe baseline and compare CVD risks between full populations of T1D vs. T2D patients. All T1D and T2D patients in Sweden were identified in... 
Myocardial infarction | Cerebral infarction | Kidney diseases | Hypoglycemia | Heart diseases | Age
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 06/2017, Volume 19, Issue 6, pp. 831 - 841
To investigate the association of novel oral glucose-lowering drugs (GLDs), compared with that of insulin, with risk of all-cause mortality, cardiovascular... 
cardiovascular disease | type 2 diabetes | DPP | hypoglycaemia | dapagliflozin | pharmaco‐epidemiology | 4 inhibitor | pharmaco-epidemiology | DPP-4 inhibitor | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - etiology | Hypoglycemia - epidemiology | Administration, Oral | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Humans | Middle Aged | Risk Factors | Proportional Hazards Models | Male | Cause of Death | Propensity Score | Sweden | Hypoglycemia - etiology | Diabetes Mellitus, Type 2 - mortality | Cardiovascular Diseases - epidemiology | Female | Glucosides - therapeutic use | Registries | Aged | Diabetes Mellitus, Type 2 - drug therapy | Benzhydryl Compounds - therapeutic use | Diabetes Mellitus, Type 2 - complications | Type 2 diabetes | Drugs | Medical research | Patient outcomes | Mortality | Glucose | Epidemiology | Insulin | Heart attack | Dextrose | Prescribing | Medicine, Experimental | Comparative analysis | Peptidase | Diabetes mellitus | Regression analysis | Hypoglycemia | Patients | Beta blockers | Risk factors | Sodium | Diabetes | Cardiovascular diseases | Health risk assessment | Index Medicus | DPP‐4 inhibitor | Original | Clinical Medicine | Medical and Health Sciences | Endokrinologi och diabetes | Medicin och hälsovetenskap | Klinisk medicin | Endocrinology and Diabetes | pharmacoepidemiology
Journal Article
Journal Article
The Lancet, ISSN 0140-6736, 06/2002, Volume 359, Issue 9324, pp. 2140 - 2144
Glycometabolic state at hospital admission is an important risk marker for long-term mortality in patients with acute myocardial infarction, whether or not... 
MORTALITY | MEDICINE, GENERAL & INTERNAL | ADMISSION | INSULIN-TREATMENT | PROGNOSIS | TOLERANCE | RISK | INFUSION | TERM | CORONARY-HEART-DISEASE | STRESS HYPERGLYCEMIA | Body Mass Index | Glucose Tolerance Test | Prevalence | Prospective Studies | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Male | Myocardial Infarction - metabolism | Sweden - epidemiology | Diabetes Mellitus, Type 2 - epidemiology | Diabetes Mellitus, Type 2 - diagnosis | Glucose - metabolism | Female | ROC Curve | Hemodynamics | Measurement | Physiological aspects | Glucose metabolism | Glucose intolerance | Glucose tolerance tests | Heart attack | Cardiovascular disease | Heart attacks | Glucose | Diabetes | Metabolism | Medical screening | Myocardial infarction | Laboratories | Identification methods | Family medical history | Blood | Hyperglycemia | Diagnosis | Cardiology | Heart failure | Hypertension | Fasting | Risk groups | Abnormalities | Diabetes mellitus | Angina pectoris | Patients | Discharge | Blood levels | Disease prevention | Glucose tolerance | Infarction | Index Medicus | Abridged Index Medicus | Hemoglobin A; Glycosylated/metabolism | Myocardial Infarction/metabolism | Diabetes Mellitus; Type 2/diagnosis/epidemiology | Glucose/metabolism | Research Support; Non-U.S. Gov't | Hemodynamic Processes | Sweden/epidemiology
Journal Article
Circulation, ISSN 0009-7322, 07/2017, Volume 136, Issue 3, pp. 249 - 259
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 06/2018, Volume 71, Issue 23, pp. 2628 - 2639
Journal Article
Diabetes, ISSN 0012-1797, 06/2019, Volume 68, Issue Supplement 1, p. 206
The aim was to assess the development and mortality risks associated with heart failure (HF) or chronic kidney disease (CKD) in T2D patients. T2D patients... 
Myocardial infarction | Cerebral infarction | Vascular diseases | Diabetes mellitus | Mortality | Renal failure | Kidney diseases | Diabetes | Cardiovascular diseases | Diabetes mellitus (non-insulin dependent) | Heart diseases
Journal Article
Heart, ISSN 1355-6037, 12/2007, Volume 93, Issue 12, pp. 1577 - 1583
Journal Article